It has become almost axiomatic in the pharmaceutical world that litigation has replaced
innovation as the primary mode of operation, says the head of the Canadian Generic …

Well, if that tweak advances medical science in any way, then the answer to that question is
“yes,” according to Patrick Kierans, the global head of pharmaceuticals and life sciences for …

Evergreening--the act of improving preexisting technology and patenting those
improvements--is beneficial. This Comment focuses on the concept of evergreening, a …

Pharmaceutical companies rely on patenting medicines in order to shield their invention
from competition and to maximize profits. Pharmaceutical companies use their power and …

In April 2013, the Indian Supreme Court decided Novartis AG v. Union of India.'This case
has sparked discussion surrounding the practice of" evergreening" in the pharmaceutical …

In today's fast-paced world where Americans crave a quick fix to their medical woes, it takes
more than advice on a healthy lifestyle to satisfy consumers. But along with cutting-edge …

Abstract'Evergreening'is not a formal concept of patent law. It is best understood as a social
idea used to refer to the myriad ways in which pharmaceutical patent owners utilise the law …

There is a widespread perception that drug prices in the US are much higher than they
should be, and that the problem is only getting worse. Critics argue that the pharmaceutical …

This thesis identifies some of the uncertainties surrounding the application of Article 102 of
the Treaty on the Functioning of the European Union (TFEU) to evergreening of …

As discussed in Part I, a patent is usually granted for twenty years. However, a special
circumstance exists in the case of pharmaceutical companies. Such companies are granted …